Twelve days after tumour inoculation, IRAPTcellko mice showed a significantly increased tumour mass in comparison with the control mice, and a strongly reduced infiltration of the tumour not only by ovalbumin-specific CD8+ T cells but also by the whole CD8+ T-cell population (Fig. 7a; Supplementary Fig. 8a). This evidence concerns the gene CD8A and neoplasm.